Latest Equities News

Condor Energy has wrapped up its Technical Evaluation Agreement work programme ahead of schedule, reinforcing the multi-billion barrel oil and gas potential in Peru's Tumbes Basin and setting the stage for licence conversion and strategic partnerships.

Fat Prophets Global Contrarian Fund (ASX: FPC) has disclosed the Dividend Reinvestment Plan (DRP) price for its six-month dividend ending December 2025, applying a 2.5% discount to the volume weighted average price, resulting in a DRP price of AUD 1.35 per share.

Andromeda Metals has wrapped up the Early Works phase at its Great White Project, setting the stage for construction and trimming the equity funding needed for the next development stage to about $40 million.

Cuscal Limited has successfully raised A$30 million through a fully underwritten institutional placement to fund its acquisition of Paymark. The company also launched a Share Purchase Plan targeting an additional A$3 million from eligible shareholders.

The Qualitas Real Estate Income Fund (ASX: QRI) has raised its March 2026 distribution yield to 7.25% annualised, reflecting a completed investment loan on assets needing repositioning amid ongoing high interest rates.

Cuscal Limited is set to acquire New Zealand payments provider Paymark for A$27 million, funded by a fully underwritten A$30 million institutional placement and a non-underwritten A$3 million share purchase plan. The deal, expected to complete by June 2026, will add scale and geographic diversification while being accretive to earnings in FY27.

Simble Solutions has finalized its acquisition of Next Nano, issuing 600 million shares to the vendor, while also completing a $2.5 million two-tranche placement with attaching options.

NewPeak Metals has completed a significant drilling campaign at its Tansey Gold Project with assay results due soon, while gearing up for a substantial drill program at Las Opeñas in Argentina. The company holds $1.4 million cash and a notable stake in Lakes Blue Energy as it weighs options for its uranium assets.

Vectus Biosystems has completed the sale of its VB4-P5 renal fibrosis compound to Canadian biotech XORTX, receiving a near 10% equity stake and warrants. This move aligns with Vectus’ strategy to develop drug candidates to a stage attractive to partners while focusing on its lead compound VB0004.

Mindax Limited pushes forward its vision for a Mid-West iron ore processing hub with metallurgical testing and strategic investments, while managing a cash runway under one quarter and preparing further capital raises.

Cadence Opportunities Fund weathered a sharp March selloff to deliver a robust 35.9% gain for the 2026 financial year so far, while announcing a fully franked interim dividend of 7.5 cents per share.

Tamboran Resources Corporation is extending its capital raise with a partially underwritten retail entitlement offer worth up to A$27 million, following a US$163 million institutional and public offering. The proceeds will accelerate drilling and resource delineation in the Beetaloo Basin, aiming to underpin first gas sales in 2026.